Series B funding round for Pyxis Oncology raising $150M in March 2021
Series B funding round for Pyxis Oncology raising $150M in March 2021
| Investor | Firm Type | Partner |
|---|
RTW InvestmentsLEAD | Hedge Fund | — |
Arix BioscienceLEAD | Venture Capital | — |
| Private | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Hedge Fund | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$172M
Top Valuation
-
Pyxis Oncology raised $150M in a Series B round.
The round was announced on 03/01/21.
The round was led by Christian Schetter, gotham makker.